JP2024526939A5 - - Google Patents
Info
- Publication number
- JP2024526939A5 JP2024526939A5 JP2024503840A JP2024503840A JP2024526939A5 JP 2024526939 A5 JP2024526939 A5 JP 2024526939A5 JP 2024503840 A JP2024503840 A JP 2024503840A JP 2024503840 A JP2024503840 A JP 2024503840A JP 2024526939 A5 JP2024526939 A5 JP 2024526939A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- ester
- progression
- rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224679P | 2021-07-22 | 2021-07-22 | |
| US202163224690P | 2021-07-22 | 2021-07-22 | |
| US202163224674P | 2021-07-22 | 2021-07-22 | |
| US63/224,690 | 2021-07-22 | ||
| US63/224,674 | 2021-07-22 | ||
| US63/224,679 | 2021-07-22 | ||
| PCT/US2022/038072 WO2023004151A1 (en) | 2021-07-22 | 2022-07-22 | Methods for inhibiting the progression of oxidative retinal diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526939A JP2024526939A (ja) | 2024-07-19 |
| JP2024526939A5 true JP2024526939A5 (cg-RX-API-DMAC7.html) | 2024-07-29 |
Family
ID=84979648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503840A Pending JP2024526939A (ja) | 2021-07-22 | 2022-07-22 | 酸化的網膜疾患の進行を抑制する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250099415A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4373479A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526939A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240036651A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022313207A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3227139A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310210A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023004151A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240091187A1 (en) * | 2022-09-02 | 2024-03-21 | Biojiva Llc | Pharmaceutical compositions of d10-docosahexaenoic acid or esters thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060270739A1 (en) * | 2005-04-28 | 2006-11-30 | Trustees Of Tufts College | Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation |
| US20100303887A1 (en) * | 2007-07-30 | 2010-12-02 | Bazan Nicolas G | DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells |
| EP2219638A2 (en) * | 2007-10-29 | 2010-08-25 | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | Lipoxin a4 protection for retinal cells |
| US10058522B2 (en) * | 2011-04-26 | 2018-08-28 | Retrotope, Inc. | Oxidative retinal diseases |
| WO2017091279A1 (en) * | 2015-11-23 | 2017-06-01 | Retrotope, Inc. | Site-specific isotopic labeling of 1, 4-diene systems |
| WO2020102596A1 (en) * | 2018-11-15 | 2020-05-22 | Retrotope, Inc. | Deuterated compounds, compositions, and uses |
-
2022
- 2022-07-22 EP EP22846695.9A patent/EP4373479A4/en active Pending
- 2022-07-22 CA CA3227139A patent/CA3227139A1/en active Pending
- 2022-07-22 KR KR1020247005941A patent/KR20240036651A/ko active Pending
- 2022-07-22 IL IL310210A patent/IL310210A/en unknown
- 2022-07-22 WO PCT/US2022/038072 patent/WO2023004151A1/en not_active Ceased
- 2022-07-22 AU AU2022313207A patent/AU2022313207A1/en active Pending
- 2022-07-22 CA CA3311344A patent/CA3311344A1/en active Pending
- 2022-07-22 JP JP2024503840A patent/JP2024526939A/ja active Pending
- 2022-07-22 US US18/291,016 patent/US20250099415A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3558458B1 (en) | Glyceryl 3-hydroxybutyrates for migraine symptom management | |
| JP4151853B2 (ja) | エイコサペンタエン酸および/またはステアリドン酸を含む治療用薬剤 | |
| AU2014236004B2 (en) | Compositions and methods for producing elevated and sustained ketosis | |
| JP4596734B2 (ja) | スタチン副作用の処置 | |
| KR20040004652A (ko) | 조효소 q 및 에이코사펜타에노산(epa) | |
| JPH06157303A (ja) | 脂肪酸治療 | |
| CN1638753A (zh) | 脂肪酸治疗效果的强化 | |
| JP2025510369A5 (cg-RX-API-DMAC7.html) | ||
| JP2001510799A (ja) | 必須脂肪酸および生物活性ジスルフィドを含む治療用および食餌療法用組成物 | |
| JPH0714873B2 (ja) | 局所性製薬組成物 | |
| NZ577731A (en) | Compositions and methods for treatment of multiple sclerosis | |
| JP2022521233A5 (cg-RX-API-DMAC7.html) | ||
| RU2005107416A (ru) | Эйкозапентаеновая кислота (эпк) для лечения нервно-психической анорексии (на) и булимии | |
| JP2025031720A5 (cg-RX-API-DMAC7.html) | ||
| US6288026B1 (en) | Process and composition for treating diseases with an oil-in-water emulsion | |
| US8299121B2 (en) | Softgel of NLKJ for treating prostate diseases | |
| CA2364606C (en) | Oil-in-water emulsion for the use as medicament or for producing a medicament | |
| JPH0399011A (ja) | 医薬組成物 | |
| McCarty | High-chromium yeast for acne? | |
| JPS5998018A (ja) | 老化治療剤 | |
| JP2024526939A (ja) | 酸化的網膜疾患の進行を抑制する方法 | |
| JP5952556B2 (ja) | 褥瘡治療剤 | |
| JP5710150B2 (ja) | 潜伏性感染疾患の再発抑制剤 | |
| CA2504280A1 (en) | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease | |
| ES2425045T3 (es) | Acetil-L-carnitina para la prevención de la neuropatía diabética periférica dolorosa |